Whittier Trust’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,292
Closed -$22K 1516
2020
Q3
$22K Buy
+2,292
New +$21.8K ﹤0.01% 990
2020
Q2
Sell
-2,292
Closed -$14K 1557
2020
Q1
$14K Hold
2,292
﹤0.01% 1060
2019
Q4
$28K Hold
2,292
﹤0.01% 962
2019
Q3
$26K Hold
2,292
﹤0.01% 978
2019
Q2
$23K Hold
2,292
﹤0.01% 936
2019
Q1
$30K Hold
2,292
﹤0.01% 879
2018
Q4
$35K Hold
2,292
﹤0.01% 854
2018
Q3
$46K Hold
2,292
﹤0.01% 793
2018
Q2
$45K Hold
2,292
﹤0.01% 784
2018
Q1
$46K Hold
2,292
﹤0.01% 795
2017
Q4
$30K Hold
2,292
﹤0.01% 861
2017
Q3
$42K Hold
2,292
﹤0.01% 775
2017
Q2
$42K Hold
2,292
﹤0.01% 749
2017
Q1
$52K Hold
2,292
﹤0.01% 705
2016
Q4
$80K Hold
2,292
﹤0.01% 628
2016
Q3
$56K Hold
2,292
﹤0.01% 675
2016
Q2
$55K Hold
2,292
﹤0.01% 701
2016
Q1
$54K Hold
2,292
﹤0.01% 704
2015
Q4
$69K Buy
+2,292
New +$74K ﹤0.01% 665

Whittier Trust's AMAG Position: Q4 2020 in Review

Whittier Trust sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,292 shares — an estimated $22K sold.

Whittier Trust first reported a position in AMAG in Q4 2015 and held it in 19 quarters. The position peaked at $80K in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Whittier Trust reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Whittier Trust sold 2,292 AMAG Pharmaceuticals shares in Q4 2020, an estimated $22K.
  • Whittier Trust first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 19 quarters.
  • Whittier Trust's AMAG Pharmaceuticals position peaked at $80K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Whittier Trust's 13F filing for Q4 2020, filed 29 Jan 2021.